Wu Qi, Qin Xiao-juan, Tang Yan-tian, Hu Ze, Zhang Shun-an, Yao Xue-yan
Department of Internal Medicine-Cardiovascular, Beilun District People's Hospital of Ningbo, Ningbo 315800, China. Email:
Zhonghua Liu Xing Bing Xue Za Zhi. 2013 Apr;34(4):396-8.
To study the damage on organs from salt sensitivity hypertension or non-salt-sensitive hypertension and the selection of drug combination.
120 hypertensive patients including 60 cases salt-sensitive (SS) and 60 non-salt-sensitive (NSS) groups were selected in our hospital and their salt load tested. These two groups were randomly divided into two groups, each group with 30 patients, one was given felodipine and perindopril and the others were given indapamide sustained release tablets and perindopril to facilitate the 12-week treatment. Before and after the treatment, patients were tested for physiological indicators, such as sitting blood pressure, 24-hour ambulatory blood pressure, insulin resistance index, comparing changes of various sub-index etc.
Significantly different were seen in indices as fasting blood glucose and serum creatinine (P < 0.01), fasting insulin, left ventricular mass index, urinary albumin, body mass index, insulin resistance indices, while between the SS group and the NSS group (P < 0.05). In the SS group, when patients with various sub-indicators were using perindopril combined with indapamide treatment, the related detected indicators tended to be normal and with statistically significant differences (P < 0.05). In the NSS group, those related indexes also tended to be more normal when using felodipine combined with perindopril. However, there were statistically significant differences between the two groups (P < 0.05).
On SS hypertensive patients with target organ damages, perindopril and indapamide seemed to be more effective in NSS patients, indicating that the use of perindopril and felodipine combination, seemed to be more suitable.
研究盐敏感性高血压和非盐敏感性高血压对器官的损害以及药物联合方案的选择。
选取我院120例高血压患者,分为盐敏感(SS)组60例和非盐敏感(NSS)组60例,进行盐负荷试验。将两组患者随机分为两组,每组30例,一组给予非洛地平和培哚普利,另一组给予吲达帕胺缓释片和培哚普利,进行为期12周的治疗。治疗前后检测患者的生理指标,如坐位血压、24小时动态血压、胰岛素抵抗指数等,比较各项子指标的变化等。
空腹血糖、血清肌酐、空腹胰岛素、左心室质量指数、尿白蛋白、体重指数、胰岛素抵抗指数等指标在SS组和NSS组之间差异有统计学意义(P<0.05),空腹血糖和血清肌酐差异有极显著统计学意义(P<0.01)。在SS组中,患者使用培哚普利联合吲达帕胺治疗时,各项相关检测指标趋于正常,差异有统计学意义(P<0.05)。在NSS组中,使用非洛地平联合培哚普利时,相关指标也趋于更正常。然而,两组之间差异有统计学意义(P<0.05)。
对于有靶器官损害的SS高血压患者,培哚普利和吲达帕胺似乎比NSS患者更有效,表明使用培哚普利和非洛地平联合似乎更合适。